Fill in the missing piece on your journey to publication Enter the draw

Publishing research using ab65357? Please let us know so that we can cite the reference in this datasheet.

ab65357 has been referenced in 7 publications.

  • Song SY  et al. Inhibitory effect of ent-Sauchinone on amyloidogenesis via inhibition of STAT3-mediated NF-?B activation in cultured astrocytes and microglial BV-2 cells. J Neuroinflammation 11:118 (2014). PubMed: 24985096
  • Jin P  et al. Anti-inflammatory and anti-amyloidogenic effects of a small molecule, 2,4-bis(p-hydroxyphenyl)-2-butenal in Tg2576 Alzheimer's disease mice model. J Neuroinflammation 10:2 (2013). Functional Studies ; Mouse . PubMed: 23289709
  • Barbero-Camps E  et al. APP/PS1 mice overexpressing SREBP-2 exhibit combined Aß accumulation and tau pathology underlying Alzheimer's disease. Hum Mol Genet 22:3460-76 (2013). PubMed: 23648430
  • Kindy MS  et al. Deletion of the cathepsin B gene improves memory deficits in a transgenic ALZHeimer's disease mouse model expressing AßPP containing the wild-type ß-secretase site sequence. J Alzheimers Dis 29:827-40 (2012). PubMed: 22337825
  • Hook G  et al. The cysteine protease inhibitor, E64d, reduces brain amyloid-ß and improves memory deficits in Alzheimer's disease animal models by inhibiting cathepsin B, but not BACE1, ß-secretase activity. J Alzheimers Dis 26:387-408 (2011). PubMed: 21613740
  • Wen L  et al. VPS35 haploinsufficiency increases Alzheimer's disease neuropathology. J Cell Biol 195:765-79 (2011). PubMed: 22105352
  • Cui J  et al. Morphine protects against intracellular amyloid toxicity by inducing estradiol release and upregulation of Hsp70. J Neurosci 31:16227-40 (2011). PubMed: 22072674

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"